Virtual Library

Start Your Search

  • WCLC 2020

    2020 World Conference on Lung Cancer

    Conference Program for the 2020 World Conference on Lung Cancer

    Presentation Date(s):  
    • January 28 - 31, 2021
    • Total Presentations: 1597

    To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.

    Presentations will be available 24 hours after their live presentation time

Filter Results:

Show Only Available Presentations

  • +

    P15 - Immuno-biology and Novel Immunotherapeutics (Phase I and Translational) - Novel Immunotherapeutics (Phase I)

    • Type: Posters
    • Track: Immuno-biology and Novel Immunotherapeutics (Phase I and Translational)
    • Presentations: 8
    • Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
    • +

      P15.03 - A Phase 1/1b Study of Lazertinib as Monotherapy and in Combination with Amivantamab in Advanced EGFR-Mutated NSCLC

      00:00 - 00:00  |  Presenter: Koichi Goto

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    P76 - Targeted Therapy - Clinically Focused - EGFR

    • Type: Posters
    • Track: Targeted Therapy - Clinically Focused
    • Presentations: 98
    • Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
    • +

      P76.73 - MARIPOSA: Randomized Phase 3 Study of First-line Amivantamab + Lazertinib vs Osimertinib vs Lazertinib in EGFR-mutant NSCLC

      00:00 - 00:00  |  Presenter: S. Martin Shreeve

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P76.74 - PAPILLON: Randomized Phase 3 Study of Amivantamab Plus Chemotherapy vs Chemotherapy Alone in EGFR Exon20ins NSCLC

      00:00 - 00:00  |  Presenter: Trishala Agrawal

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    P86 - Targeted Therapy - Clinically Focused - New Target

    • Type: Posters
    • Track: Targeted Therapy - Clinically Focused
    • Presentations: 23
    • Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
    • +

      P86.12 - Cardiac Safety Assessment of Lazertinib in Patients with EGFR Mutation-Positive Advanced Non-Small Cell Lung Cancer

      00:00 - 00:00  |  Presenter: Nahor Haddish-Berhane

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.